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C.E.O. & Chief Cardiac Surgeon, National Heart Institute, New Delhi, IndiaAn interesting case report on anaortic total arterial off-pump
coronary artery bypass surgery (OPCAB) published later in
the journal, only go to attest the fact that there is no limit to
technical ingenuity and permutation and combinations that
can be drawn to do bypass surgery. After all heart needs blood,
no matter how it comes. Compliments to the authors because
the ‘whole’ that they have achieved is definitelymore than the
sum of the parts viz Anaortic, Total Arterial and OPCAB. Lets
look at the parts independently with a view to answering the
conundrum e Can anaortic total arterial OPCAB be considered
the best form of surgical revascularisation, as advocated by
the authors?1. Anaortic Grafting
Cerebrovascular accidents (CVA) continue to be a thorn in the
flesh of a cardiac surgeon.1e3 Saha et al (later in the journal)
have extolled the virtues of anaortic total arterial OPCAB. Let
me play a devil's advocate to putmatters in perspective. Of the
protean ways that one can develop CVA following bypass
surgery, showering of the atheromatous debris from the aorta
is the commonest, with aortic clamping the modus operandi,
irrespective of it being a ‘cross clamp’ or a partial side bitting
clamp.4 Clampless anaortic bypass has been advanced to
address this issue5 and results far superior to conventional
CABG (stroke 1.3 vs 3.4%; p-0.32) and comparable to PCI arm of
the SYNTAXTrial (stroke 1.3 vs 2.0%; p-0.347)were achieved in
the aortic no-touch OPCAB subgroup by Arrigoni et al.6 How-
ever, other mechanisms like water-shed ischemic infarcts, in
situ thrombus, intracranial bleeds, embolization from cardiac
and other sites, do continue to operate and exhibit as strokes,
albeitmuch less commonly. Not withstanding all this anaortic
total arterial bypass does reduce the incidence of stroke.7
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which too minimizes athero-embolism based neurological
complications.8
Anaortic grafting essentially involves Pedicled Internal
Mammary Artery (IMA) based single or double inflow with all
grafts hitched as composite ‘T’ or ‘Y’ grafts. The initial fears of
the flow being insufficient, especially in presence of Left
Ventricular (LV) hypertrophy, has largely been dispelled with
demonstration that the IMA size increases with time and
being a dynamic graft, it adjusts the flow to the demands of
the myocardium.9,10 Further there is both randomized and
observational evidence that composite grafting does not
compromise graft patency or survival.11
However, no matter what technique one takes, to err is
human and err we all, and that too at most inopportune mo-
ments. Technical errors may occur in best of hands and upto
3e5% grafts are blocked on the operating table.12 Infact Man-
nacio et al, in a series of 148 cases undergoing Coronary Artery
Bypass Surgery with a composite of LIMA-Radial ‘Y’ Graft,
found scintigraphic evidence of stress induced ischemia in 24
patients at 3 years, even though clinical adverse events were
rare.13
Spasm is the Achilles heal of all arterial grafts and IMA,
histo-anatomically a somatic artery, is capable of undergoing
severe spasm leading to transmuralmyocardial infarction and
even death.14 Endothelin and Thromboxane A2 are potent
vasoconstrictors of the IMA and both have been found to be
elevated during cardiopulmonary bypass, and have been
incriminated in peri-operative IMA spasm.15 Other realistic
modes of graft failure are harvest related conduit trauma, pre-
existing vascular pathology and competitive flow mediated
string sign.
In this milieu therefore, when anaortic total arterial
bypass, places ‘all eggs in limited baskets’, it is very important
that some form of intra operative assessment of grafts,ump coronary artery bypass grafting for diffuse coronary diseasee
reserved.
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techniques,16 must be resorted to in order to pick and remedy
inadvertent errors, and thereby avoid potentially disastrous
consequences. Bonatti et al showed that three out of 23 pa-
tients needed graft revision based on intra operative angiog-
raphy.17 This is likely to be much higher in a technically
demanding subset of patients, such as those with diffuse
disease, where not only the coronary arteries are small in size,
but also the tissue planes get obliterated with severe inflam-
matory reaction and fibrosis.2. Off pump vs pump surgery
After initial rapid proliferation of OPCABworldwide, the tempo
dampened somewhat because of consistent reports of incom-
plete revascularisation18,19 and the first ever RCT comparing
the two procedures, the Randomized On/Off Bypass study
(ROOBY), showing that at one year follow up OPCAB patients
hadworse composite outcomesof death,myocardial infarction
(MI), graft patency and repeat revascularisation.20 Patency of
grafts placed Off-Pumpwas sub-optimum even in the one year
follow up angiography study of the ROOBY Cohort as also the
DOORS Study.21 ROOBY study was challenged because of sur-
geons' inexperience.22 However, it found support in a Cochrane
reviewmeta analysis fromCopenhagen,23which showed a 30%
higher risk of all cause mortality with OPCAB as compared to
On-Pump CABG, along with a slightly lower number of distal
anastomoses. To the contrary, meta analysis by Afilalo et al24
and BHACAS I & II Trials by Angelini et al25 lent support to
Off-Pump ideologues. Best Bypass Surgery26 and CORONARY27
trials were equivocal with no difference between primary
composite end points of death, MI, stroke and renal failure but
secondary outcomes, especially use of bloodproducts, bleeding
and acute kidney injury were marginally less in OPCAB. Even
though the German Off-Pump Coronary Artery Bypass in
Elderly (GOPCABE) Study28 showed no benefit of off-pump over
on-pump surgery in matters of neurological events, there is
compelling evidence to the contrary7,8,29,30 with a 35% reduc-
tion in CVA for OPCAB Versus On-Pump Surgery in STS Adult
Cardiac Surgery database (OR 0.65; p-0.001).31 All this confusion
seemnot todampenthe indomitable spirit of the Indiancardiac
surgeons, who persist with OPCAB with no clear objective evi-
dencesupporting this enthusiasm.Whatever little evidencewe
have is anecdotal case reports, with no level of evidence ‘A’
literature emanating from this country to support Off-Pump
surgery. As against, western literature keeps churning high
quality data and delivering knock out blows, the final one being
fromSepehripour et al,32who looking at Off-Pump vsOn-Pump
surgery in a total of 25 articles published in world literature,
according to a structured protocol, systematically demolished
OPCAB.3. Total arterial revascularisation (TAR)
Despite in-controvertible evidence favoring use of bilateral
IMAs33 (Ref. Table 1) e indeed ‘an inconvenient truth’,34 their
use is appallingly low (4.1e12.6%),11 which in Bruce Lytle's
words, ‘borders on the unethical’. Infact Bannon35 makes aplea for eschewing the adhoc or default use of saphenous vein.
However, all these pleadings & implorings make no headway
with thematerialistic mind set of time-poor cardiac surgeons,
who infact side step the real issues of labor intensiveness of
the procedure and time constraint, in the garb of increased
sternal morbidity attendant to bilateral IMAs, as also a po-
tential for steal in distal LIMA-LAD.36 By the same token, even
though LIMA to LAD remains a gold standard, use of two IMAs
do not translate into twice the goodness of single IMA.
Taggart et al,37 in the ART Trial, have clearly shown that
the early outcomes upto one year are exactly the same in
terms of mortality, CVA, MI and repeat revascularisation.
Cons of bilateral IMAs include increased length of operation,
increased ventilation time, increased sternal wound recon-
struction (1.9% vs 0.6%) and increasedwound complications in
diabetic patients.37 Increase in sternal infection in bilateral
IMAs was shown even by Raza et al,38 but it did not have any
effect on survival. To the contrary bilateral IMAs reduced the
mortality by 21%. The risk factors for deep sternal wound
infection were shown to be female sex (80% increased risk),
body mass index (7% increase per/kg/meter2), diabetes melli-
tus (73% increase), previous MI (58% increase) and presence of
peripheral vascular disease (73% increase). Skeletonization of
IMA may preserve sternal blood supply and decrease the risk
of sternal infection especially in diabetic patients.39 However,
Agrifoglio et al,40 Momim et al41 and Chung et al42 did not
encounter increased sternal wound infection in their series of
bilateral IMAs, even in diabetics.
Salutary effects of bilateral IMA on long term survival43,44
and their safety and efficacy even in diabetics were quite
conclusively demonstrated by Lev-Ran et al45 with freedom
from cardiac mortality at 7 years of 92% vs 68% with LIMA
alone (p < 0.0001). Conservative arguments against use of TAR
in elderly patients, those with LV or renal dysfunction and in
emergency settings have been systematically eroded by
accumulating evidence,46 thus mandating that surgical com-
munity better yield, however, discretion is the better part of
valor and despite there being no absolute contraindications,
prudence demands that Bilateral IMAs be avoided in patients
with insulin dependent diabetes mellitus, significant obesity
and chronic obstructive airway disease34 and possibly a friable
and osteoporotic sternum. Miscellaneous issues like long
elapsed time of operation, hypothermia, specially in elderly,
obese and diabetic patients and the potential for rare, but
devastating, complications like bilateral phrenic nerve
palsy,11 should also be considered in decisionmaking. So even
though bilateral IMAs definitely improve survival, reduce
MACE and repeat revascularisation rates on long term
basis,43,46,47 marginally increased short term risks, though
mitigated but not eliminated in contemporary surgical prac-
tice, should always be factored in.
The LIMA e RA anastomosis, even though practiced
routinely,48 seems jarring to an intuitive mind as the vessel
wall quality of the two is totally different, one being elastic
and the other a muscular artery, and therefore must play a
second fiddle to LIMA-RIMA ‘Y’ grafting, which match
perfectly and blend sublimely.
Lastly let us not forget that all we are doing is epicardial
revascularisation, and touch we cannot the micro circulation.
Even sub-optimum techniques like ‘soft-spot-any-where’
Table 1 e Summary of large cohort studies comparing use of bilateral and single internal mammary artery grafts for coronary artery bypass surgery (Vallely et al11).
Author Year N Description Age Results
BIMA SIMA BIMA SIMA BIMA SIMA
Taggart 2001 1989e1999
(publication
dates)
4693 11,269 Meta-analysis of 7 (non-randomized) studies;
each study at least 4 y follow-up
BIMA: HR death 0.81 (95% CI,
0.70e0.94)
Berreklouw 2001 1985e1990 249 233 Retrospective, consecutive patients; excluded
patients with reoperations, free IMAs,
gastroepiploic artery grafts, combined
procedures; mean follow-up 10 y
53.7 ± 8 56.0 ± 8.1 13 y ischemic event-free
survival 47.5% (±8.4%) HR 1.6
(95% CI, 1.3e2.3)
13 y ischemic event-free
survival 35.4% (±5.1%)
Lytle 2004 1971e1989 1152 1152 Retrospective, propensity score matched;
primary isolated CABG, non-emergent patients;
excluded patients with other arterial grafts; mean
follow-up 16.5 y
57.5 ± 8.1 57.8 ± 8.3 Survival BIMA: 7 y-89%; 10y-
81%; 15y-67%; 20y-50%; all
BIMA us. SIMA P < 0.0001
Survival SIMA: 7 y-87%; 10y-
78%; 15y-58%; 20y-37%
Ruttman 2011 2001e2010 277 724 Retrospective, consecutive patients; BIMA
vs LIMA/RA; primary, non-emergent CABG;
excluded MI within 1 week; follow-up57.7
months
56.6 ± 9.6 59.9 ± 7.9 MACCE 1.4%; RR 1.4%; MI 0.4%.
Survival HR 0.23 (95% CI, 0.07
e0.81)
MACCE 7.6%; RR 5.2%; MI3.6%
Taggart 2010 2004e2007 1548 1554 Multicenter RCT; included those considered for
CABG with multi-vessel disease; excluded
patients with evolving MI, single grafts, re-
operations; follow-up 1 y
63.7 ± 8.7 63.5 ± 9.1 Mortality 1.2%. Sternal wound
breakdown 1.9%
Mortality 1.2%. Sternal wound
breakdown0.6%
Grau 2012 1994e2010 928 928 Retrospective, propensity score matched;
included all patients undergoing isolated CABG;
excluded single grafts, use of radial artery
60.9 ± 9 62.1 ± 9 Survival: 1 y-99%; 3 y-96%; 10 y-
89%; 15y-79%
Survival: 1 y-99%; 3y-91%; 10y-
79%; 15y-61%
BIMA, bilateral internal mammary artery; CABG, coronary artery bypass grafting; CI, confidence interval; HR, hazard ratio; IMA, internal mammary artery; MACCE, major adverse cardiac and
cerebrovascular events; MI, myocardial infarction; RA, radial artery; RCT, randomized controlled trial; RR, repeat revascularisaion; SIMA, single internal mammary artery.
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bypass may have to be resorted to in more than an occasional
case, besides the standard techniques of sequential grafting.
Alternative modalities like cell & gene based therapies,
transmyocardial laser revascularisation and heart trans-
plantation toomay have a role in an anecdotal case. Therefore
in patients with diffuse disease, the extent of relief of
myocardial ischemia is at best subjudice. Even in a standard
bypass surgery, one third of patients do throw up a positive
stress test (No functional testing has been reported post
operatively by Saha et al). Absence of angina (specially in a
diabetic patient) and patency of grafts are not equivalent to
lack of ischemia. Probably it is only a reduction of the quantum
of the ischemia. No wonder then that Mannacio et al49 found
that multiple composite grafts, albeit adequate at rest, were
unable tomeet flow requirements duringmaximal hyperemia.
They issued a caveat, “In daily practice, their usemust be not a
choice but rather a necessity in those patients without alter-
native options” e Indeed a provocative statement, not
endorsed by yours truly, but nevertheless a view point.
Though the index case had excellent results, yet it is a
serious operation (lasting 12 h!) with potential for major
complications. Further such operations are not meant for the
bourgeois class among us and even for the experienced, they
are a reckoning and hence, the indications for surgerymust be
true. Patient must have ‘unacceptable’ ischemic symptoms
despite guideline directed optimum medical therapy. (Saha
et al have not mentioned the indication for surgery).
I shall end with a quote from Prof. James Tatoulis46 from
Melbourne, ‘There are many unresolved questions. Should
coronary arteries of <1.5 mm internal diameter, those sup-
plying infarcted areas, those with distal disease be grafted?
Will it make any difference? If grafted, what with? Are there
any benefits to place more than one graft (particularly arterial
grafts) in to each coronary territory? Is there still a role for
extensive coronary endarterectomy? Despite 55 years of cor-
onary surgery practice, these questions remain unresolved’.
So, whats the best form of myocardial revascularisation? e
Probably none is second to the one provided by Nature. Be
honest and true to your conscience before you prescribe one!Conflicts of interest
The author has none to declare.r e f e r e n c e s
1. Mohr FW, Morice MC, Kappetein AP, et al. Coronary artery
bypass graft surgery versus percutaneous coronary
intervention in patients with three-vessel disease and left
main coronary disease: 5-year follow-up of the randomized,
clinical SYNTAX trial. Lancet. 2013;381:629e638.
2. Farkouh ME, Domanski M, Sleeper LA, et al. Strategies for
multivessel revascularization in patients with diabetes. N
Engl J Med. 2012;367:2375e2384.3. Weintraub WS, Grau-Sepulveda MV, Weiss JM, et al.
Comparative effectiveness of revascularization strategies. N
Engl J Med. 2012;366:1467e1476.
4. Emmert MY, Seifert B, Wilhelm M, et al. Aortic no-touch
technique makes the difference in off-pump coronary
artery bypass grafting. J Thorac Cardiovasc Surg.
2011;142:1499e1506.
5. Guerrieri Wolf L, Abu-Omar Y, Choudhary BP, et al. Gaseous
and solid cerebral microembolization during proximal aortic
anastomoses in off-pump coronary surgery: the effect of an
aortic side-biting clamp and two clampless devices. J Thorac
Cardiovasc Surg. 2007;133:485e493.
6. Arrigoni SC, Mecozzi G, Grandjean JG, et al. Off-pump no-
touch technique: 3 year results compared with the SYNTAX
trial. Interact Cardiovasc Thorac Surg. 2015. http://dx.doi.org/
10.1093/icvts/ivv012.
7. Edelman JJ, Sherrah AG, Wilson MK, et al. Anaortic, total
arterial, off pump coronary artery bypass surgery e Why
bother? Heart Lung Circ. 2013;22:161e170.
8. Emmert MY, Grunenfelder J, Scherman J, et al. HEART
STRING enabled no-touch proximal anastomosis for off
pump coronary artery bypass grafting: current evidence
and technique. Interact Cardiovasc Thorac Surg.
2013;17:538e541.
9. Gaudino M, Di Mauro M, Iaco AL, et al. Immediate flow
reserve of Y thoracic artery grafts: an intra-operative
flowmetric study. J Thorac Cardiovasc Surg.
2003;126:1076e1079.
10. Glineur D, Boodhwani M, Poncelet A, et al. Comparison of
fractional flow reserve of composite Y grafts with saphenous
vein or right internal thoracic arteries. J Thorac Cardiovasc
Surg. 2010;140:639e645.
11. Vallely MP, Edelman JJB, Wilson MK. Bilateral internal
mammary arteries: evidence and technical consideration.
Ann Cardiothorac Surg. 2013;2:570e577.
12. Balacumaraswami L, Taggart DP. Intraoperative imaging
techniques to assess coronary artery bypass graft patency.
Ann Thorac Surg. 2007 Jun;83:2251e2257.
13. Mannacio V, De Vita A, Antignano A, et al. Y grafts with the
left internal mammary artery and radial artery. Mid-term
functional and angiographic results. Cohort study. Int J Surg.
2014;12:952e957.
14. Ziadinov E, Al-Kemyani N, Al-Sabti H. Management of
internal mammary artery spasm. J Cardiol Clin Res.
2014;2:1028e1032.
15. Yildiz O, Seyrek M, Gul H. Pharmacology of Arterial Grafts for
Coronary Artery Bypass Surgery; 2013:251 [Chapter 15] http://dx.
doi.org/10.5772/54723.
16. Nakata K, Sankai Y, Akiyama K, et al. Evaluation of a new
device for the intra-operative assessment of coronary artery
bypasses grafting. Ann Thorac Cardiovasc Surg.
2011;17:160e165.
17. Bonatti J, Danzmayr M, Schachner T, et al. Intra operative
angiography for quality control in MIDCAB and OPCAB. Eur J
Cardiothorac Surg. 2003;24:647e649.
18. Robertson MW, Buth KJ, Stewart KM, et al. Complete
revascularisation is compromised in off-pump coronary
artery bypass grafting. J Thorac Cardiovasc Surg.
2012;145:992e998.
19. Hannan EL, Wu C, Smith CR, et al. Off pump versus on-pump
coronary artery bypass graft surgery: differences in short-term
outcomes and in long-termmortality and need for subsequent
revascularisation. Circulation. 2007;116:1145e1152.
20. Shroyer AL, Grover FL, Hattler B, et al. For the Veterans Affairs
Randomized On/Off Pump Bypass (ROOBY) Study Group. On
pump versus off-pump coronary artery bypass surgery. N Engl
J Med. 2009;361:1827e1837.
i n d i a n h e a r t j o u r n a l 6 7 ( 2 0 1 5 ) 1 9 6e2 0 020021. Houlind K, Fenger-Gron M, Holme SJ, et al. Graft patency after
off pump coronary artery bypass surgery is inferior even with
identical heparinisation protocols: results from the Danish on
pump versus off pump randomized study (DOORS). J Thorac
Cardiovasc Surg. 2011;148:1812e1819.
22. Puskas JD, Mack MJ, Smith CR. On-pump versus off-pump
CABG. N Engl J Med. 2010;362:851e854.
23. Moller CH, Penninga L, Wetterslev J, et al. Off-Pump versus
on-pump coronary artery bypass grafting for ischaemic heart
disease. Cochrane Database Syst Rev. 2012:CD007224.
24. Afilalo A, Rasti M, Ohayon SM, et al. Off-Pump versus on-
pump coronary artery bypass surgery: an updated meta
analysis and meta-regression of randomized trials. Eur Heart
J. 2012;33:1257e1267.
25. Angelini GD, Culliford L, Smith DK, et al. Effects of on-and off-
pump coronary artery surgery on graft patency, survival and
health-related quality of life: long-term follow-up of 2
randomized controlled trials. J Thorac Cardiovasc Surg.
2009;137:295e303.
26. Moller CH, Perko MJ, Lund JT, et al. Three years follow up in a
subset of high risk patients randomly assigned to off pump
versus on pump coronary artery bypass surgery: the Best
Bypass surgery trial. Heart. 2011;97:907e913.
27. Lamy A, Devereaux PJ, Prabhakaran D, et al. Off-pump or on-
pump coronary artery bypass grafting at 30 days. N Engl J Med.
2012;366:1489e1497.
28. Diegeler A, Borgermann J, Kappert U, et al. Off pump versus
on pump coronary artery bypass grafting in elderly patients.
N Engl J Med. 2013;368:1189e1198.
29. Sabban MA, Jalal A, Bakir BM, et al. Comparison of
neurological outcomes in patients undergoing conventional
coronary artery bypass grafting on-pump beating heart
coronary bypass and off-pump coronary bypass. Neurosciences
(Riyadh). 2007;12:35e41.
30. Attarabsheh SE, Deo SV, Rababa'h AM, et al. Off-pump
coronary artery bypass reduces early stroke in octogenarians:
a meta-analysis of 18000 patients. Ann Thorac Surg. 2015.
http://dx.doi.org/10.1016/j.athorac sur.2014.12.057.
31. Puskas JD, Edwards FH, Pappas PA, et al. Off pump techniques
benefit men and women and narrow the disparity in
mortality after coronary artery bypass grafting. Ann Thorac
Surg. 2007;84:1447e1454.
32. Sepehripour AH, Chaudhry UAR, Harling L, et al. Off pump or
on pump beating heart: which technique offers better
outcomes following coronary revascularisation. Interact
Cardiovasc Thorac Surg. 2015;20:546e549.
33. Davierwala PM, Mohr FW. Bilateral internal mammary artery
grafting: rationale and evidence. Int J Surg. 2015;16:133e139.
34. Tatoulis J. Total arterial coronary revascularisation-patient
selection, stenoses, conduits, targets. Ann Cardiothorac Surg.
2013;2:499e506.
35. Bannon PG, Yan TD. Total arterial revascularisation e the
evidence, the reality and the dilemma. Foreword Ann
Cardiothorac Surg. 2013;2:388.
36. Buxton BF, Hayward PA. The art of arterial revascularisation
e total arterial revascularisation in patients with triple vesselcoronary artery disease. Ann Cardiothorac Surg.
2013;2:543e551.
37. Taggart DP, Altman DG, Gray AM, et al. Randomized trial to
compare bilateral versus single internal mammary coronary
artery bypass grafting: a 1 year results of the Arterial
Revascularisation Trial (ART). Eur Heart J.
2010;31:2470e2481.
38. Raza SG, Benedetto U, Husain M, et al. Does grafting of the left
anterior descending artery with the insitu right internal
thoracic artery have an impact on late outcomes in the
context of bilateral internal thoracic artery usage. J Thorac
Cardiovasc Surg. 2014;148:1275e1281.
39. Peterson MD, Borger MA, Rao V, et al. Skeletonisation of
bilateral internal thoracic artery grafts lowers the risk of
sternal infection in patients with diabetes. J Thorac Cardiovasc
Surg. 2003;126:1314e1319.
40. Agrifoglio M, Trezzi M, Barili F, et al. Double vs single internal
thoracic artery harvesting in diabetic patients: role in peri-
operative infection rate. J Cardiothorac Surg. 2008;3:35e36.
41. Momim AU, Deshpande R, Potts J, et al. Incidence of sternal
infection in diabetic patients undergoing bilateral internal
thoracic artery grafting. Ann Thorac Surg. 2005;80:1765e1772.
42. Chung S, Kim WS, Jeong DS, et al. Outcomes of off-pump
coronary bypass grafting with the bilateral internal thoracic
arteries for left ventricular dysfunction. J Korean Med Sci.
2014;29:69e75.
43. Weiss AJ, Zhao S, Tian DH, et al. A meta-analysis comparing
bilateral internal mammary arteries with left internal
mammary artery for coronary artery bypass grafting. Ann
Cardiothorac Surg. 2013;4:390e400.
44. Lytle BW, Blackstone EH, Loop FD et al. Two internal thoracic
artery grafts are better than one. J Thorac Cardiovasc Surg
117; 855e872.
45. Lev-Ran O, Braunstein R, Nesher N, et al. Bilateral versus
single internal thoracic artery grafting in oral treated diabetic
subsets: comparative seven year outcome analysis. Ann
Thorac Surg. 2004;77:2039e2045.
46. Kurlansky PA, Traad EA, Dorman MJ, et al. Thirty year follow
up defines survival benefit for second internal mammary
artery in propensity matched groups. Ann Thorac Surg.
2010;90:101e108.
47. Galbut DL, Kurlansky PA, Traad EA, et al. Bilateral internal
thoracic artery grafting improves long term survival in
patients with reduced ejection fraction: a propensity matched
study with 30 years follow up. J Thorac Cardiovasc Surg.
2012;143:844e853.
48. Buxton BF, Shi WY, Tatoulis J, et al. Total arterial
revascularisation with internal thoracic and radial artery
grafts in triple vessel coronary artery disease is associated
with improved survival. J Thorac Cardiovasc Surg.
2014;148:1238e1244.
49. Mannacio V, Cirillo P, Mannacio L, et al. Multiple composite
grafts (K, p or double-Y) in coronary artery surgery: a choice
or a necessity. Interact Cardiovasc Thorac Surg. 2015;20:60e66.
